|
Orthovita, Inc. - Company Profile Snapshot
| Company Profile: |
Orthovita, Inc. |
| Ticker: |
VITA |
| Exchanges: |
NAS |
| 2008 Sales: |
76,915,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Medical, Surgical & Dental Suppliers |
| Country: |
UNITED STATES |
| Employees: |
234 |
Business Description
Orthovita, Inc.. The Group's principal activity is to develop, manufacture and market synthetic bone substitutes for orthopaedic applications that are useful in spine and joint replacements. The Group develops and markets synthetic-based biomaterial products for use in spine surgery, the repair of osteoporotic fractures, and a range of clinical needs in the trauma, joint reconstruction, revision and extremities markets. The products are based on two platforms: The products include VITOSS Bone Graft Substitute technology platforms, which are designed to address the non-structural, bone-graft market and VITAGEL Surgical Hemostat, which is a matrix for soft-tissue healing.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
